Recombinant expression of proteins from secretory cell lines
US6110707A · kind A · utility
39Cited by
5References
41Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 17, 1997 |
| Grant date | Aug 29, 2000 |
| Priority date | — |
| Expiry date | Jan 17, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/575
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention a provides methods for production of heterologous polypeptides, for example amylin, using recombinantly engineered cell lines. Also described are methods engineering cells for high level expression, methods of large scale heterologous protein production, methods for treatment of disease in vivo using viral delivery systems and recombinant cell lines, and methods for isolating novel amylin receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.